|
|
Other links at Articles > Business of Medicine |
| 1. |
Economic Consequences of Early Breast Cancer Treatment Often Severe
|
|
|
With absence from work averaging 7.5 months among women treated for early breast cancer, lost wages are often the most important financial cost of the disease, according to a Canadian study reported in the Journal of the National Cancer Institute for March 5. Reuters Health Information
|
| 4. |
Genzyme Recalls Three Transplant Drug Lots: U.S. FDA
|
|
|
Genzyme Corp has voluntarily recalled three lots of Thymoglobulin, its injectable drug for transplant patients, after one lot failed a stability test, the U.S. Food and Drug Administration said on Thursday. Reuters Health Information
|
|
|
